Skip to main content

Universities in Nottingham to play a key role in the development of a potential DNA vaccine against COVID-19

Scientists at the University of Nottingham and Nottingham Trent University will contribute essential virology expertise to help develop a safe and effective vaccine to prevent COVID-19.

Universities in Nottingham to play a key role in the development of a potential DNA vaccine against COVID-19

A hand, wearing a bright blue glove, holds a small glass bottle with a white cap. The bottle is labelled with a white label which reads “Coronavirus COVID-19 Vaccine – injection only – 15 ml – Store frozen”.

“As the COVID-19 pandemic has unfolded, Scancell has been evaluating how it can best contribute its expertise and resources to help in the global response. Vaccines are the long-term solution and we believe our approach has the potential to produce a second-generation vaccine that will generate an effective and durable immune response to COVID-19.”

Professor Lindy Durrant, Chief Scientific Officer at Scancell, and Professor of Cancer Immunotherapy at the University of Nottingham